DNA 0.00% 3.2¢ donaco international limited

hands up who took their full allocation, page-56

  1. 1,742 Posts.
    lightbulb Created with Sketch. 80
    From the 30th Jan Investor Presentation:
    DEC HALF:
    - REVENUE: $7.7m
    - EBITDA: Small Loss

    DEC HALF (normalised):
    - REVENUE: $11.7m
    - EBITDA: $6.6m

    Also from the 30th Jan Investor Presentation:
    FY 2015 ESTIMATES:
    - REVENUE: $38.8m
    - EBITDA: $22.4m

    That would mean they are expecting:
    JUN HALF:
    - REVENUE: $31.1m
    - EBITDA: $22.4m

    Seems ambitious?
 
watchlist Created with Sketch. Add DNA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.